Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296 | ISIN: INE935A01035 |Industry: Pharmaceuticals
|Expensive Rocket
Durability score
55 /100
Valuation score
27.5 /100
Momentum score
68.9 /100
Market Capitalizati...
18,573.8 Cr.
AVG Broker Target
661.6
PE TTM Price to Ear...
20.6
Fetching latest news from server
  • Stock Price (664.25) crossed above 30 Day SMA (641.53) on 11 December, 2018
  • Stock Price (647.0) crossed above 50 Day SMA (628.49) on 07 December, 2018
  • HDFC Securities increased Buy price target of Glenmark Pharmaceuticals Ltd. to 790.0 on 15 Nov, 2018.
  • Stock Price (620.00) crossed above 100 Day SMA (606.01) on 31 October, 2018
  • Stock Price (556.00) crossed below 150 Day SMA (562.71) on 18 July, 2018
More triggered alerts
Ex-Date Dividend Amount Dividend Type Record Date
Sept. 19, 20182.00FINAL-
Sept. 20, 20172.00FINAL-
Aug. 3, 20162.00FINAL-
Sept. 10, 20152.00FINAL-
July 10, 20142.00FINAL-
All dividends by GLENMARK
Ex-Date Dividend Bonus Ratio Record Date
March 4, 20051:1-
All bonuses by GLENMARK
Ex-Date Dividend Old FVNew FV Record Date
Sept. 10, 200721-
Oct. 23, 2003102Oct. 31, 2003
All splits by GLENMARK